Hostname: page-component-8448b6f56d-42gr6 Total loading time: 0 Render date: 2024-04-19T02:09:17.466Z Has data issue: false hasContentIssue false

Recent Patterns of Addiction in Czechoslovakia

Published online by Cambridge University Press:  29 January 2018

V. VondráČek
Affiliation:
Charles University, Prague 2, Ke Karlovu 11, Czechoslovakia
J. Prokupek
Affiliation:
Institute of Postgraduate Training, Prague 8, Bohnice, Czechoslovakia
R. Fischer
Affiliation:
Psychiatric Clinic, Charles University, Prague 2, Czechoslovakia
M. Ahrenbergová
Affiliation:
University Hospital, Prague 2, Czechoslovakia

Extract

There is no uniformity in the use of the terms habituation, addiction, intense desire, and craving. V. Petran (19) talks of craving as the irresistible desire to acquire a drug and the impossibility of abstaining from it. Craving may be manifested immediately after first consumption, but addiction represents a regular use, from which craving may develop in time.

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1968 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Battegay, R. (1957). “Sucht nach Abusus von Doriden.” Praxis, 45:991992.Google Scholar
2. Brandon, S. (1963). “Addiction to amphetamines.” Brit. Med. J. 2:1204.CrossRefGoogle Scholar
3. Cerna, H. (1966). “Symptomatic psychoses in phenmetrazine addiction.” Prague, unpublished. (In Czech).Google Scholar
4. Connell, P. H. (1958). Amphetamine Psychosis, London.Google Scholar
5. Eitinger, L., Retterstöl, H., Sund, A. (1962). “Meprobamate addiction and habituation.” Pyschopharm. Abstr. 2:693.Google Scholar
6. Evans, J. (1959). “Psychosis and addiction to phenmetrazine (Preludin).” Lancet, ii, 7095:152.CrossRefGoogle Scholar
7. Grumlik, R., Hosakova, Z., Topiar, A. “Psychotic disease in course of prolonged therapy with phenmatrazine.” 5th Psychopharmacological Seminar, Jesenik 1963 (in Czech).Google Scholar
8. Grumlik, R., Rampacek, J., Topiar, A. (1966). “Mental illnesses caused by phenmetrazine and dexphenmetrazine.” Cs. psychiat. Google Scholar
9. Grunilund, K. (1962). “Phenacetin abuse in Swedish industry.” Psychopharm. Abstr. 2:1860.Google Scholar
10. “Habituation to amphetamine.” (1963). Pharmaceut. J. 190:22.Google Scholar
11. Kasanen, A. (1962). “The phenacetin problem in Finland.” Psychopharm. Abstr. 2:1712.Google Scholar
12. Klvanova, H., Gral, T., Cigar, J., Medvedcky, J., Majer, I. (1961). “On the problem of drug-caused agranulocytoses.” Sborn. Lek. Fak. Universit. P. J. Safarika, Kosice, 4, 1:143150.Google Scholar
13. Lancet (1959), ii, 374.Google Scholar
14. Libansky, J., Chrobak, L., Mrkos, D., Fortynova, J., Cernik, F., Semrad, O. (1962). “Depressions of blood formation caused by drugs.” Cas. Lek. Ces. 51:14941502.Google Scholar
15. Little, J. C. (1963). “A case of primary addiction to meprobamate.” Brit. Med. J. ii, 294.CrossRefGoogle Scholar
16. McConnell, W. B. (1963). “Amphetamine substances in mental illnesses in Northern Ireland.” Brit. J. Psychiat., 109, 218224.CrossRefGoogle Scholar
17. Modlin, H. C., Montes, A. (1964). “Narcotic addiction in physicians.” Amer. J. Psychiat., 121, 4: 358365.CrossRefGoogle Scholar
18. Modr, Z., Pechek, B. (1966). “Evolution of drug consumption in CSSR, from 1952 to 1964.” Cas. Lek. Ces, 105, 18: 473479.Google Scholar
19. Petran, V. (1960). “Some comments on addictions.” Cas. Lek. Ces, 34:10791082.Google Scholar
20. Proksova, A., Nemecek, J. (1959). “Psychic complications in Preludin therapy.” Cs. Psychiat., 55:368.Google Scholar
21. Sattes, H. (1962). “Zur Anthropologic der Rauschmittelsucht.” Nervenarzt, 33:185187.Google Scholar
22. Vondráček, V. (1958) in Riedl and Vondráček: Clinical Toxicology. State Publ. House of Medical Literature, Prague (in Czech).Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.